Knee long segment occlusion: drug-eluting stents than with paclitaxel-coated balloon
Drug-eluting stents (drug-eluting stents, DES) for below-knee arterial lesions and shorter long been clear, and for a long period knee artery disease, growing evidence supports the use of paclitaxel-coated balloon (paclitaxel-coated balloons , PCB) treatment.
To this end, researchers from Greece and the United Kingdom conducted a study called IDEAS. The results showed that, compared with the PCB, DES in the treatment of long below-knee arterial disease, postoperative residual stenosis less, six months after the reduction was also significantly better than the PCB vascular stenosis, article published in September this year in JACC.